Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Amneal Pharma Acquires Generic Business of Actavis Australia 13
Amneal Pharma Acquires Four Generic Products from Actavis for USD10 Million 14
Partnerships 16
Amneal Pharma Enters into Licensing Agreement with mAbxience 16
Merger 17
Amneal Merges with Impax 17
Licensing Agreements 19
Amneal Pharma Enters into Licensing Agreement with Jerome Stevens Pharma 19
Amneal Pharma Enters into Licensing Agreement with Adello Biologics 20
Amneal Pharma Enters into Development and Licensing Agreement with Iconovo 21
Amneal Pharma Enters Into Licensing Agreement With Hanmi Pharma For Nexium Alternative 22
Equity Offering 23
Amneal Pharma Plans to Raise Funds through Public Offering of Shares 23
Amneal Pharma to Raise USD854 Million in Private Placement of Shares 24
Debt Offering 25
Amneal Pharma Raises USD600 Million in Private Placement of 2% Notes Due 2022 25
Asset Transactions 26
ANI Pharma to Acquire Generic Products from Amneal Pharma and Impax Labs 26
ANI Pharma to Acquire Manufacturing Equipment from Amneal Pharma and Impax Labs 28
Acquisition 29
Aristo Pharma Acquires Amneal Nordic and Amneal Pharma Spain 29
Novartis May Acquire Amneal Pharma 30
Amneal Pharma Plans to Acquire Epsilon Pharma for up to USD16.9 Million 31
Amneal Pharmaceuticals Inc – Key Competitors 32
Amneal Pharmaceuticals Inc – Key Employees 33
Amneal Pharmaceuticals Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 36
Financial Announcements 36
Aug 09, 2018: Amneal Announces Solid Second Quarter 2018 Financial Results 36
Mar 02, 2018: Amneal 4th Quarter Full Year 2017 Quarterly Financial Report 39
Corporate Communications 42
Feb 06, 2018: Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations 42
Dec 18, 2017: Robert Stewart to Join Amneal Pharma as President 43
Dec 18, 2017: Robert Stewart to Join Amneal Pharmaceuticals as President 44
Clinical Trials 45
Apr 21, 2017: Impax to Present Data on Investigational Drug IPX203 at the 2017 American Academy of Neurology Annual Meeting 45
Other Significant Developments 46
May 11, 2018: Amneal Announces Actions to Streamline Operations and Capture Cost Synergies 46
Jan 23, 2018: PSEG Long Island Presents Amneal Facility with Energy-Efficiency Rebates 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Amneal Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Amneal Pharma Acquires Generic Business of Actavis Australia 13
Amneal Pharma Acquires Four Generic Products from Actavis for USD10 Million 14
Amneal Pharma Enters into Licensing Agreement with mAbxience 16
Amneal Merges with Impax 17
Amneal Pharma Enters into Licensing Agreement with Jerome Stevens Pharma 19
Amneal Pharma Enters into Licensing Agreement with Adello Biologics 20
Amneal Pharma Enters into Development and Licensing Agreement with Iconovo 21
Amneal Pharma Enters Into Licensing Agreement With Hanmi Pharma For Nexium Alternative 22
Amneal Pharma Plans to Raise Funds through Public Offering of Shares 23
Amneal Pharma to Raise USD854 Million in Private Placement of Shares 24
Amneal Pharma Raises USD600 Million in Private Placement of 2% Notes Due 2022 25
ANI Pharma to Acquire Generic Products from Amneal Pharma and Impax Labs 26
ANI Pharma to Acquire Manufacturing Equipment from Amneal Pharma and Impax Labs 28
Aristo Pharma Acquires Amneal Nordic and Amneal Pharma Spain 29
Novartis May Acquire Amneal Pharma 30
Amneal Pharma Plans to Acquire Epsilon Pharma for up to USD16.9 Million 31
Amneal Pharmaceuticals Inc, Key Competitors 32
Amneal Pharmaceuticals Inc, Key Employees 33
Amneal Pharmaceuticals Inc, Other Locations 34
Amneal Pharmaceuticals Inc, Subsidiaries 34
List of Figures
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9